The FDA is defending its increased use of non-binding guidance documents rather than legally-enforceable rulemakings, arguing that guidance can better keep pace with the latest …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
“This was worse than our national election.” — Eric Peterson, MD, MPH, cardiologist and FDA advisory committee member, discussing his vote in support of elamipretide
Share this article According to GlobalData’s company profile on Bristol-Myers Squibb, Cancer treatment biomarkers was a key innovation area identified from patents. Bristol-Myers Squibb‘s grant
Cardiovascular disease is the leading cause of death in patients suffering from lupus, an autoimmune disease in which our immune system attacks our own tissues